恒瑞医药在港上市,创新药出海能否追上百济神州?

《财经》杂志
23 May

恒瑞医药赴港上市并成为近五年港股最大医药IPO,这是其出海战略的关键一步,但目前公司海外收入仍较小,创新药出海仍有待突破   文|康国亮   在A股龙头公司赴港上市大潮下,港股市场5月23日迎来一家A股创新药龙头公司——恒瑞医药(600276.SH,1276.HK)。   当日,恒瑞医药登陆港交所,开盘股价大涨超30%,截至发稿,股价上涨35.07%至59.5港元/股,总市值达到3929亿港元,其...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10